Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 928 of 1,261
  1. US 8153690

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

    Esperion Therapeutics, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  2. US 8148571

    Compound, composition comprising the same, and process for production of polymerizable amide

    Kuraray Medical Inc. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  3. US 8147840

    Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  4. US 8147845

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  5. US 8148576

    Solid state forms of aliskiren compounds

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  6. US 8148510

    Antifungal polypeptides

    The Regents of the University of California · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  7. US 8148560

    Vaginal tablets comprising misoprostol and methods of making and using the same

    TEVA WOMEN'S HEALTH, INC. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  8. US 8148525

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  9. US 8148340

    Immunomodulatory oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  10. US 8148352

    Antimicrobial therapy for bacterial infections

    The Regents of the University of California · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  11. US 8148367

    Renin inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  12. US 8148149

    Methods of inducing tubulogenesis and/or branching morphogenesis of kidney cell cultures

    The Regents of the University of California · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  13. US 8148323

    Method of treating or inhibiting inflammation by multi-domain amphipathic helical peptides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  14. US 8148344

    Compositions and methods for mediating RNAi in vivo

    Alnylam Pharmaceuticals, Inc. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  15. US 8148343

    Tumor suppressor factor

    Molecular Discover Systems · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  16. US 8148356

    Acetylcysteine composition and uses therefor

    Cumberland Pharmaceuticals Inc. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  17. US 8148328

    Salicylanilides enhance oral delivery of therapeutic peptides

    The Regents of the University of California · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  18. US 8147807

    Oral composition for dental purposes

    Kuraray Medical Inc. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  19. US 8148378

    Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal

    Xenon Pharmaceuticals Inc. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  20. US 8147805

    Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications

    The Board of Regents of the University of Texas System · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  21. US 8147833

    Prevention and treatment of synucleinopathic and amyloidogenic disease

    The Regents of the University of California · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  22. US 8147828

    Methods and compositions for modulation of blood-neural barrier

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  23. US 8148107

    High affinity human antibodies to human nerve growth factor

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  24. US 2012076825

    PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF

    WEBSTER HEATHER MICHELLE [US] · Granted Mar 29, 2012 · Expires Mar 24, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.